AGP Limited (AGP): 1QCY25 EPS clocked-in at PKR 3.04, up 1.1xYoY - By Taurus Research

Apr 30 2025


Taurus Securities


  • 1QCY25: – EPS: PKR 3.04, PAT: PKR 1.0Bn, up 1.3xYoY, in line with expectations.
  • AGP’s topline clocked-in at PKR 7.1Bn for 1QCY25, mainly benefitting from the deregulation of non essential medicines and increase in prices of multiple essential medicines. Gross margins increased ~4pptsYoY by arriving at ~58% as compared to ~53% in the SPLY (as expected) driven by higher prices of medicines.
  • Finance costs arrived at PKR 385Mn as compared to PKR 730Mn, down 47%YoY/27%QoQ driven by lower policy rate and the Company’s reduced borrowings. Whereas, tax rate arrived at 40% compared to 37%.
AGP Limited (AGP): 1QCY25 EPS clocked-in at PKR 3.04, up 1.1xYoY - By Taurus Research

Apr 30 2025


Taurus Securities


  • 1QCY25: – EPS: PKR 3.04, PAT: PKR 1.0Bn, up 1.3xYoY, in line with expectations.
  • AGP’s topline clocked-in at PKR 7.1Bn for 1QCY25, mainly benefitting from the deregulation of non essential medicines and increase in prices of multiple essential medicines. Gross margins increased ~4pptsYoY by arriving at ~58% as compared to ~53% in the SPLY (as expected) driven by higher prices of medicines.
  • Finance costs arrived at PKR 385Mn as compared to PKR 730Mn, down 47%YoY/27%QoQ driven by lower policy rate and the Company’s reduced borrowings. Whereas, tax rate arrived at 40% compared to 37%.
AGP Limited (AGP): CY24 Corporate Briefing Takeaways - By Taurus Research

Apr 28 2025


Taurus Securities


  • AGP Limited was incorporated as a public limited company in May 2014. The Company got listed on Pakistan Stock Exchange Limited on 05 March 2018. The principal activities of the Company include import, marketing, export, dealership, distribution, wholesale and manufacturing of all kinds of pharmaceutical products.
  • In CY24, stand-alone revenue clocked in at PKR 18.5Bn compared to PKR 13.8Bn, up 34% over the SPLY. While consolidated revenue clocked in at PKR 25Bn as compared to PKR 18.7Bn, up 34% driven by higher prices. Consolidated gross margins increased 4ppts arriving at 58% compared to 54% in the SPLY primarily attributable to pass on effects of prices to customers.
  • Finance costs arrived at PKR 2.6Bn compared to PKR 1.6Bn, up 65% in the SPLY driven by higher interest rates on the back of higher borrowing requirement. Similarly, effective tax rate clocked in at 33% compared to 31% mainly due to the higher tax rate and shift to normal tax regime. Consequently, PAT arrived in at PKR 2.9Bn as compared to PKR 1.8Bn, up 64% over the SPLY. Resultantly, earnings increased by 70% arriving at PKR 9.53/sh compared to PKR 5.59/sh
AGP Limited (AGP): Corporate Briefing Notes - By Chase Research

Apr 28 2025



  • AGP Limited reported a net profit of PKR 2.08 billion (EPS: PKR 7.44) in CY24, reflecting a 75% increase compared to PKR 1.19 billion (EPS: PKR 4.25) in the previous year.
  • Net sales rose 34% YoY to PKR 18.54 billion, while consolidated revenue reached PKR 25.03 billion, up from PKR 18.74 billion in SPLY. Growth was driven by a 21% increase in volumes and a 13% price impact. Consolidated gross margins improved to 58.1% from 53.6% in the SPLY, while operating margins expanded to 28.5% from 22.7%, attributed to successful price adjustments and operational efficiencies
  • Management highlighted that recent acquisitions have contributed significantly to performance, with a 5-year consolidated revenue CAGR of 38%, of which 52% was driven by inorganic growth.
AGP Limited (AGP): Profitability prospects to remain attractive; Buy - By JS Research

Apr 25 2025


JS Global Capital


  • We preview 1QCY25 earnings for AGP Limited (AGP), expecting the company to post consolidated earnings of Rs861mn, up 2.2x YoY, taking EPS to Rs3.07. The significant rise in profitability is primarily driven by rise in drug prices with higher nonessential mix, increase in sales volume, and lower finance costs.
  • On QoQ basis, profitability is likely to witness a dip owing to relatively lower margins (compared to the previous quarter with peak sales volumes/ margins). Accordingly, we expect gross margins to hover around 59% in 1QCY25, down 5ppts QoQ.
  • While seasonal factors weighed on quarterly margins, annual gross margins are expected to remain stable, underpinned by a higher non-essential mix (>60%), softer API prices, and the full internalization of the Viatris portfolio by end-CY25.
AGP Limited (AGP): 4QCY24 expected EPS of PKR 2.86, up 35%YoY - By Taurus Research

Feb 26 2025


Taurus Securities


  • 4QCY24: – EPS: PKR 2.86, PAT: ~PKR 849Mn, up ~35% over the SPLY.
  • AGP’s topline is expected to arrive-in at ~PKR 7.8Bn for 4QCY24, mainly benefitting from the deregulation of non essential medicines and the Government’s decision of increasing prices of multiple essential medicines. Currently, AGP's revenue mix is evenly split between essential and non-essential medicines on a consolidated basis. Similarly, we expect the gross margin to hover around 54%, aligning with the Company’s historic trend.
  • For CY24, sales are expected to clock-in at ~PKR 25Bn, up 36%YoY. However, the upside in revenue is likely to be off-set by increase in expenses, finance cost and taxation, up 33%/64%/67% YoY resulting in EPS of PKR 8.12. We expect future earnings to follow the same trend as the Company is expected to benefit from deregulation, looking forward.
AGP Limited (AGP): Deregulation to boost 4QCY24 bottom-line - By JS Research

Jan 21 2025


JS Global Capital


  • We preview 4QCY24 earnings for AGP Limited (AGP), where we expect earnings to register 71% YoY growth, arriving at Rs3.63/share mainly driven by higher prices post deregulation of non-essential medicines implemented majorly during 3QCY24, making 4Q the first quarter reflecting the major impact of the recent change. We also expect volumetric growth to support AGP’s bottom-line growth.
  • Cumulatively, CY24E EPS (consolidated) accumulates to Rs8.89 (+59% YoY). Alongside results, we expect AGP to announce a final cash dividend of Rs3.5/share for CY24.
  • The stock has rallied 49% in the past 3 months, however, has underperformed the Pharma sector. We believe the underperformance is unwarranted given the company’s higher earnings growth profile and attractive valuations. We reiterate our Buy rating for the stock, offering 36% upside to our Dec-2025 TP of Rs250.
AGP Ltd (AGP): Unlocking value through strong growth; Buy – By JS Research

Nov 19 2024


JS Global Capital


  • We reinstate coverage on AGP Ltd (AGP) with a Target Price of Rs220/share; implying an upside of 48% from current levels
  • strong growth trajectory - AGP is well-positioned for 5-year revenue CAGR of 16% (CY24-CY29E), driven by its robust product portfolio, expanding distribution network, and strategic acquisitions (Sandoz and Viatris).
  • cost optimization and industry-leading margins – with expectations to maintain next 5-year average gross margins at 59%, vis-à-vis historical 5-year average gross margins of 55%.
Market Wrap: Highlights of the day - By JS Research

May 23 2025


JS Global Capital


  • Dull activity was observed on the last trading day of the week at the PSX, as investors adopted a cautious stance and preferred to stay on the sidelines ahead of the Federal Budget. The benchmark KSE-100 index fluctuated between an intraday high of 119,542 points (+389) and a low of 118,665 points (−487), before closing with a marginal loss of 50 points at 119,102. Trading volumes remained thin throughout the day, with major participation seen in sideboard stocks. Going forward, we expect the market to continue consolidating; hence, investors are advised to wait for dips before taking fresh positions.
Image Pakistan (IMAGE): Corporate Briefing Key Takeaways - By Topline Research

May 23 2025


Topline Securities


  • Topline Securities hosted a Corporate Briefing Session (CBS) for Image Pakistan (IMAGE) today, where senior management discussed the recent financial performance and future outlook of the company.
  • Rs193mn capex was incurred in 9MFY25, and management expects an additional Rs250mn for multi-head embroidery machinery and Rs150mn for store expansions over the next 9 months of CY25.
  • IMAGE currently has 14 outlets, with 4 more in progress (3 new and 1 expansion), bringing the total to 17 physical stores alongside a strong global online presence. Upcoming locations include the expanded Zamzama flagship, Bukhari Commercial in Karachi, F-6 MarkazIslamabad, and Giga Mall Rawalpindi.
Image Pakistan Limited (IMAGE): 3QFY25 Corporate Briefing Takeaways - By Taurus Research

May 23 2025


Taurus Securities


  • IMAGE is a premium fashion retailer specializing in Schiffli embroidery and digital lawn. It operates 14 stores across Pakistan and a growing online platform serving both local and international markets. With subsidiaries in the UK and USA, IMAGE targets the affordable luxury segment, blending traditional craftsmanship with modern design for its customers.
  • In 3QFY25, IMAGE reported sales of PKR 1,205 million, relatively unchanged from 3QFY24 sales of PKR 1,204 million. Gross profit margin slightly improved to 45% in 3QFY25 compared to 42% in the same period last year (SPLY). However, net profit after tax (PAT) decreased by 12% to PKR 209Mn in 3QFY25 from PKR 238Mn in the SPLY due to an increase in distribution and selling expenses. EPS stood at PKR 0.91 in 3QFY25 (3QFY24 EPS: PKR 1.81).
  • During 3QFY25, IMAGE expanded its physical presence with three new stores: Multan, Gujrat, and a new outlet at Dolmen Mall Lahore, taking total outlets to 14 nationwide. An additional three outlets (DHA Phase VI Karachi, Giga Mall Rawalpindi, and F-6 Islamabad) are scheduled for launch by the end of CY25, which will bring the total to 17 brick-and-mortar stores. This accelerated rollout indicates management’s confidence in sustained foot traffic recovery and untapped urban demand.
Market Wrap: KSE-100 Stays Resilient Amid Budget Uncertainty - By HMFS Research

May 23 2025


HMFS Research


  • The KSE-100 index exhibited a choppy trajectory today as investor sentiment remained cautious ahead of the FY26 budget announcement. Ongoing discussions with the IMF and anticipation of new conditionalities kept market participants on edge, curbing aggressive positions. Still, broader optimism anchored in improving macroeconomic fundamentals— such as expected external financing from the UAE and World Bank, and renewed efforts to enhance trade and exports—offered some stability amidst the turbulence. After hitting an intraday high of +389 points, the index ultimately settled at 119,103, recording a marginal decline of 50 points. Market activity reflected a wait-and-see approach, with muted volumes of 99.8mn shares on the KSE-100 and 337.1mn shares traded overall. Leading the board were BBFL (33mn), WTL (19mn), and DOL (16mn). Going forward, the market is likely to remain sensitive to unfolding budgetary disclosures and IMF-related developments. Nonetheless, a constructive macroeconomic backdrop could provide the necessary support to steer equities toward recovery. Investors are advised to remain vigilant, closely track policy cues, and prioritize fundamentally sound stocks with long-term value potential.
Pakistan Aluminium Beverage Cans Limited (PABC): CY24 & 1QCY25 Corporate Briefing Takeaways - By Taurus Research

May 23 2025


Taurus Securities


  • PABC is the leading manufacturer of beverage cans in Pakistan. The Company is also Pakistan’s first and only manufacturer and exporter of aluminium cans.
  • During CY24, sales revenue increased 17%YoY clocking in at PKR 23Bn. The contribution of the exports to total revenue was around 63% during the year. Export sales increased 53%YoY to PKR 14.4Bn. Gross margin recorded a marginal decrease. Net profit for the year was recorded at PKR 6Bn compared to PKR 5Bn during the SPLY. The net profit margin recorded a marginal increase. As a result, EPS increased to PKR 16.9/sh from PKR 13.9/sh during the SPLY.
  • The Company reported a production of 936Mn cans in CY24, at a capacity utilization of 89%. The production capacity is 1.2Bn cans p.a.
Lalpir Power Limited (LPL): CY24 Corporate Briefing Key Takeaways - By Taurus Research

May 23 2025


Taurus Securities


  • LPL’s Power Purchase Agreement, originally due to expire in Nov’28, was terminated effective Oct 1, 2024, under a Negotiated Settlement Agreement. Receivables up to Sep 30, 2024—including CPP, EPP, and PTI—were cleared by Dec 31, 2024. Delayed payment interest was waived, resulting in significant reversals in the financials. The Company retains ownership of its 350MW oil-fired complex, and no further compensation was provided by the Government. CPPA-G will reimburse the Company for any adverse tax rulings if applicable.
  • Revenue declined 27%YoY to PKR 14.2Bn (CY23: PKR 19.5Bn), reflecting reduced dispatches ahead of PPA expiry. Gross profit fell to PKR 3.55Bn (CY23: PKR 5.6Bn), while PAT sharply dropped to PKR 465Mn from PKR 4.9Bn. This steep decline was primarily driven by non-recurring reversals—including furnace oil inventory written down to net realizable value due to low selling prices and the reversal of interest income due to waived charges under the settlement. EPS declined significantly to PKR 1.22 (CY23: PKR 12.1).
  • LPL reported surplus funds of PKR 9.8Bn as of Dec 31, 2024, ensuring liquidity strength post-PPA. However, Management clarified that it does not plan to distribute excess reserves via dividends in the near term. Instead, the focus is on pursuing high-potential ventures that can deliver superior long-term shareholder value.
Morning News: IMF not too ‘keen’ on relief steps in budget, links them to FBR revenue - By Vector Research

May 23 2025


Vector Securities


  • Signaling its reluctance to grant a major relief to the salaried, property, beverage, and export sectors, the visiting IMF team has linked the FBR’s tax collection target with reduction in expenditures. This is the crux of the ongoing parleys, as the team is going to accomplish its visit on Friday (today). However, the Fund will make an exception for the defence budget, as Islamabad will take an appropriate decision to hike the defence spending in view of the current geopolitical environment.
  • Prime Minister Shehbaz Sharif on Thursday met with a delegation from the World Bank, led by Managing Director of Operations Anna Bjerde, to discuss the Bank’s development investment and cooperation in Pakistan. The prime minister said the government is taking practical steps to maximize benefits from the World Bank’s investment under the Country Partnership Framework. He said the framework is expected to bring more than $20 billion in development financing to Pakistan.
  • Federal Minister for Power Sardar Awais Ahmad Khan Leghari met with a delegation led by Anna Bjerde, Managing Director Operations of the World Bank, to discuss Pakistan's ongoing power sector reforms. According to a press statement issued on Thursday, the minister shared plans to launch a competitive electricity market soon, noting that preparatory work is underway. An Independent System and Market Operator (ISMO) has been established, and experienced professionals are being appointed. The government will no longer be the sole electricity purchaser.
Morning News: Forex reserves exceed $16bn mark on IMF tranche - By WE Research

May 23 2025



  • Pakistan's foreign exchange reserves rose by $1.034 billion in one week, reaching $16.649 billion as of May 16, 2025, largely due to a $1.023 billion IMF loan tranche under the Extended Fund Facility (EFF). This marks the highest level in four months. While the State Bank of Pakistan’s (SBP) reserves increased, commercial banks' reserves dipped slightly by $9 million. The IMF also approved a $1.4 billion Resilience and Sustainability Facility (RSF) to help Pakistan address climate challenges and support growth. The IMF funds are expected to attract further international financial support, with SBP projecting reserves to exceed $14 billion by June 2025.
  • World Bank Managing Director Anna Bjerde praised Pakistan’s recent economic reforms as a “globally recognised model,” crediting Prime Minister Shehbaz Sharif’s leadership for driving the transformation. During a high-level meeting in Islamabad, Bjerde highlighted Sharif’s focus on sustainable policies, political unity, and development that prioritizes people. She referred to Pakistan’s Country Partnership Framework as the “Pakistan Model,” citing its successful implementation. Sharif thanked the World Bank for its support, especially following the 2022 floods, and noted the partnership will lead to over $20 billion in development investment. Both sides reaffirmed their commitment to continued collaboration.
  • Prime Minister Shehbaz Sharif met with a World Bank delegation led by Managing Director Anna Bjerde to discuss development cooperation and the Country Partnership Framework, which is expected to bring over $20 billion in financing to Pakistan. Sharif emphasized the government’s efforts to fully leverage this investment and thanked the World Bank for its support during the 2022 floods. Bjerde praised Pakistan’s progress on macroeconomic stability and called the partnership a global model, now referred to as the “Pakistan Model.” The meeting reaffirmed strong cooperation between Pakistan and the World Bank, with several senior officials in attendance.
Morning News: WB announces USD 55m in additional funding - By Alpha - Akseer Research

May 23 2025


Alpha Capital


  • Federal Minister for Power Sardar Awais Ahmad Khan Leghari met with a delegation led by Anna Bjerde, Managing Director Operations of the World Bank, to discuss Pakistan's ongoing power sector reforms.
  • Pakistan is targeting the export of 125,000 tonnes of mangoes in the current season, with an anticipated revenue of $125 million, the Pakistan Fruit and Vegetable Exporters Association (PFVA) announced. The export campaign is set to kick off on Sunday (May 25).
  • Honda Atlas Cars Pakistan Limited (HCAR) reported a net profit of Rs2.7 billion (EPS: Rs18.97) for the year ended March 31, 2025, marking a 16 per cent year-on-year (YoY) increase and surpassing industry expectations.
Market Wrap: Highlights of the day - By JS Research

May 22 2025


JS Global Capital


  • The market opened on a positive note on Thursday, with the index gaining 767 points to hit an intraday high of 120,699. However, the momentum faded as investors opted for profit-taking at higher levels, dragging the index down to an intraday low of 119,062 before closing at 119,153, down 778 points. Going forward, range-bound activity is likely to persist ahead of the Federal Budget announcement, and investors are advised to remain cautious."
AGP Limited (AGP): 1QCY25 EPS clocked-in at PKR 3.04, up 1.1xYoY - By Taurus Research

Apr 30 2025


Taurus Securities


  • 1QCY25: – EPS: PKR 3.04, PAT: PKR 1.0Bn, up 1.3xYoY, in line with expectations.
  • AGP’s topline clocked-in at PKR 7.1Bn for 1QCY25, mainly benefitting from the deregulation of non essential medicines and increase in prices of multiple essential medicines. Gross margins increased ~4pptsYoY by arriving at ~58% as compared to ~53% in the SPLY (as expected) driven by higher prices of medicines.
  • Finance costs arrived at PKR 385Mn as compared to PKR 730Mn, down 47%YoY/27%QoQ driven by lower policy rate and the Company’s reduced borrowings. Whereas, tax rate arrived at 40% compared to 37%.
Current:
Open:
Volume:
Change: ()
High:
Low:
52 Week High:
Vol Avg(12 m):
Free Float:
52 Week Low:
Market Cap:
Total Share:

Relative Strength Index (RSI)

RSI:

MACD Signals

MACD DAILY:
MACD WEEKLY:

Simple Moving Avg (SMA)

SMA(10):
SMA(30):
SMA(60):
SMA(200):

Performance

One Month:
Three Months:
Six Months:
Twelve Months:

Support & Resistance

Support 1:
Resistance 1:
Support 2:
Resistance 2:

High & Lows

Period
High
Low